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is epidemiologically relevant. Indeed,
SARS-CoV evolved during the course
of the SARS outbreak in China (12).
Similarly, influenza is perpetuated in
the human population by the evolu-
tion of new antigenic variants every
year (Robin Bush, University of
California, Irvine) (13). Even if the
transmissibility of an emerging dis-
ease is initially below the threshold
necessary to sustain it in a population,
the potential for the organism’s evolu-
tion to higher levels may exist
(14,15). Thus, one should not become
complacent about diseases that are
repeatedly introduced through zoono-
sis, but teeter on the edge of sustain-
ability within the human population. 
The success with which WHO
coordinated the global collaboration
in containing SARS galvanized the
World Health Assembly to grant
WHO greater authority to verify out-
breaks, conduct investigations of out-
break severity, and evaluate the ade-
quacy of control measures. The out-
come of this new authority will
depend on integrating the expertise of
public health officials, medical doc-
tors, and epidemiologists worldwide
with guidance from disease transmis-
sion models. The SARS outbreak
demonstrated that an epidemic in one
part of the world is not just an individ-
ual nation’s problem but a global
problem. 
Alison P. Galvani*
*University of California, Berkeley,
California, USA
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Conference Summary
Open Access
Publishing 
An Open Access Publishing
Conference was convened in Atlanta,
Georgia, on January 7, 2004, by the
libraries of the Centers for Disease
Control and Prevention (CDC) and
Emory University. Open Access is an
emerging publishing model for peer-
reviewed scientific research in which
authors and their publishers grant free
access to their work as long as the
authors are acknowledged and the
publisher ensures that the work is
made freely available in a digital
archive (1). The conference brought
together key stakeholders including
scientists, researchers, publishers, and
librarians and included approximately
240 participants with 80 offsite regis-
trants connecting through the simulta-
neous Web cast. 
The keynote address, “The
Coming Revolution in the Publication
of Scientific Papers,” delivered by
Harold Varmus, emphasized that 1) in
today’s Internet era, the traditional
Gutenberg print publishing model is
outdated; 2) electronic publishing has
the advantages of lower costs, global
distribution, content that can be linked
to datasets, improved archiving, and
full-text searching; and 3) rigorous
peer review is possible in electronic
and Open Access formats. Open
Access publishing challenges include
engaging professional societies in this
approach, building sustainable busi-
ness plans, and changing academic
culture so that published works are
evaluated for content rather than for
the journal label. Open Access pub-
lishing is typically financed by author
fees along with a combination of phil-
anthropic and advertising support.
Examples are the Public Library of
Science, Journal of Clinical
Investigation, and BioMed Central
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journals. Recent milestones include
the Bethesda Open Access Principles
meeting (1), the Wellcome Trust
endorsement of Open Access, and
support from the Howard Hughes
Medical Foundation and a number of
leading European scientific societies. 
A panel of speakers gave stake-
holders’ perspectives. Sheldon Kotzin
reviewed the National Library of
Medicine’s (NLM) priorities regard-
ing access to, and permanent retention
of, the world’s biomedical literature.
Reflecting growing concerns about
high costs of scientific publications,
the U.S. Congress recently directed
the NLM to report on the impact of
rising journal subscription prices rela-
tive to access to medical research
information and to identify remedies
to ensure that taxpayer-funded
research remains in the public
domain. NLM’s Open Access initia-
tive is PubMed Central, a digital
archive of freely available life sci-
ences journals. After a slow start, the
PubMed Central repository includes
137 journal titles. PubMed Central
expects publishers to deposit full con-
tents of each journal issue soon after
publication. Supplementary data files
are also encouraged. The recent addi-
tion of a single article from a journal
that is not participating in PubMed
Central is broadening the definition of
this archive. Another Open Access
approach was described by John
Nickerson, editor of Emory
University’s Molecular Vision, which
has been freely available on the
Internet since its first issue in October
1995. A low-cost operation,
Molecular Vision is a refereed open
access journal that has achieved sci-
entific recognition in its field.
Publishing trends affecting
libraries were discussed by Linda
Watson, University of Virginia Health
Sciences Library, and included: 1)
journal subscription price increases
outpacing library budgets, 2) publish-
ers’ bundling of journal subscriptions
into large contracts often not well
matched with institutional research
interests, 3) consolidations in the pub-
lishing industry, 4) restrictive licens-
ing terms overriding copyright and fair
use practices, 5) long-term archival
access to electronic content, and 6)
selective deletions of published arti-
cles from databases and e-publica-
tions. Presenting a scientist’s perspec-
tive, CDC’s Marta Gwinn noted that
the scientific community’s overarch-
ing responsibility is to ensure that
research is conducted with integrity
and quality and that access to it is fair,
maximizes value to users, and protects
the public investment and interests.  
The open access conference gener-
ated discussion about the scientific
research dissemination process and
the need to strengthen the connections
between evidence-based research and
healthcare action. With high quality,
peer-reviewed scientific research
becoming freely available on the
Internet, possibilities for more rapid
advances in scientific knowledge and
ultimately improved public health are
important. Collaboration between
government and academia is neces-
sary to make progress toward open
access to scientific research.
This conference was supported in
part by the National Networks of
Libraries of Medicine, Southeastern
Atlantic Region. Conference presen-
tations are available from: http://
ada/healthsci.emory.edu/openaccess 
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Correction Vol. 10, No. 3
In “Legionella Infection Risk
from Domestic Hot Water,” by
Paola Borella et al., errors
occurred in the abstract. The sev-
enth sentence should read as fol-
lows: “Furthermore, zinc levels of
<100 µg/L and copper levels of
>50 µg/L appeared to be protec-
tive against Legionella coloniza-
tion.”
We regret any confusion these
errors may have caused.
Correction Vol. 10, No. 3
In the article “Murine Typhus with Renal
Involvement in Canary Islands, Spain” by
Michele Hernández-Cabrera et al., errors
occurred in the 2nd paragraph under The
Study on page 740: 68% should be 6.8%. The
corrected sentence appears below:
In Spain, two seroepidemiologic surveys,
in Salamanca and Madrid (Central/ Western
Spain), yielded seroprevalence rates of
12.8% and 6.8%, respectively, in the general
population (4,5). 
The corrected article appears online at
http://www.cdc.gov/ ncidod/EID/vol10no4/
03-0532.htm
We regret any confusion this error may
have caused.
Correction Vol. 10, No. 3
In the article entitled “Distribution
of Bovine Spongiform Encephalo-
pathy in Greater Kudu (Tragelaphus
strepsiceros)” by Andrew A. Cunning-
ham et al., errors occurred in the title.
The corrected title appears below:
Bovine Spongiform Encephalo-
pathy Infectivity in Greater Kudu
(Tragelaphus strepsiceros)
The corrected article appears
online at http://www.cdc.gov/
ncidod/EID/ vol10no6/03-0615.htm
We regret any confusion this error
may have caused.
